tert-Butyl 4-(6-chloropyridazin-4-yl)piperazine-1-carboxylate

Catalog No. :
ACBVZH080
CAS No. :
1824297-27-9
Molecular Formula :
C13H19ClN4O2
Molecular Weight :
298.77

IUPAC Name:tert-butyl 4-(6-chloropyridazin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(6-chloropyridazin-4-yl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$143.00Login to see priceInquiryInquiry
100mg98%$208.00Login to see priceInquiryInquiry
250mg98%$288.00Login to see priceInquiryInquiry
1g98%$678.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(6-chloropyridazin-4-yl)piperazine-1-carboxylate
IUPAC Nametert-butyl 4-(6-chloropyridazin-4-yl)piperazine-1-carboxylate
Molecular FormulaC13H19ClN4O2
Molecular Weight298.77
SMILESO=C(N1CCN(C2=CC(Cl)=NN=C2)CC1)OC(C)(C)C
InChI KeyMSWSXIGNXYNMAI-UHFFFAOYSA-N
Synonym1-Piperazinecarboxylic acid, 4-(6-chloro-4-pyridazinyl)-, 1,1-dimethylethyl ester
CAS No.1824297-27-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACBVZH080 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACENAW254 route compound structure diagram
    ACENAW2541837-55-4 In Stock
  4. Then
  5. ACBVZH080 route product structure diagram
    ACBVZH0801824297-27-9
Inquiry

2. ACBVZH080 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACUGAQ384 route compound structure diagram
    ACUGAQ3841196155-33-5 In Stock
  4. Then
  5. ACBVZH080 route product structure diagram
    ACBVZH0801824297-27-9
Inquiry

Comments (0)